Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Lynozyfic™ (linvoseltamab-gcpt) to treat adult ...

MedTech company Precisis has appointed Steven Griffiths as its Vice President of European Sales, a newly created role aimed at accelerating the company’s growth across Europe.